Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Inhaled Vaporized Cannabis on Pulmonary Function, Breathlessness and Exercise Tolerance in Symptomatic Patients With Advanced Chronic Obstructive Pulmonary Disease (COPD)

NCT03060993 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT03060993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03060993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Inhaled Vaporized Cannabis on Pulmonary Function, Breathlessness and Exercise Tolerance in Symptomatic Patients With Advanced Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
McGill University
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2017
Completion date
April 30, 2018
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breathlessness, chronic obstructive pulmonary disease (copd), exercise intolerance